Information Collection Request Submitted to OMB for Review and Approval; Comment Request; NESHAP for Pharmaceuticals Production (Renewal), 24472-24473 [2018-11449]
Download as PDF
24472
Federal Register / Vol. 83, No. 103 / Tuesday, May 29, 2018 / Notices
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OECA–2013–0356; FRL–9978–
68–OEI]
Information Collection Request
Submitted to OMB for Review and
Approval; Comment Request; NESHAP
for Group I Polymers and Resins
(Renewal)
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Environmental Protection
Agency (EPA) has submitted an
information collection request (ICR)—
NESHAP for Group I Polymers and
Resins (Renewal), EPA ICR Number
2410.04, OMB Control Number 2060–
0665—to the Office of Management and
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act. This is a proposed
extension of the ICR, which is currently
approved through May 31, 2018. Public
comments were previously requested
via the Federal Register on June 29,
2017 during a 60-day comment period.
This notice allows for an additional 30
days for public comments. A fuller
description of the ICR is given below,
including its estimated burden and cost
to the public. An agency may not
conduct or sponsor and a person is not
required to respond to a collection of
information unless it displays a
currently valid OMB control number.
DATES: Additional comments may be
submitted on or before June 28, 2018.
ADDRESSES: Submit your comments,
referencing Docket ID Number EPA–
HQ–OECA–2013–0356, to (1) EPA
online using www.regulations.gov (our
preferred method), by email to
docket.oeca@epa.gov, or by mail to: EPA
Docket Center, Environmental
Protection Agency, Mail Code 28221T,
1200 Pennsylvania Ave. NW,
Washington, DC 20460, and (2) OMB via
email to oira_submission@omb.eop.gov.
Address comments to OMB Desk Officer
for EPA.
EPA’s policy is that all comments
received will be included in the public
docket without change including any
personal information provided, unless
the comment includes profanity, threats,
information claimed to be Confidential
Business Information (CBI) or other
information whose disclosure is
restricted by statute.
FOR FURTHER INFORMATION CONTACT:
Patrick Yellin, Monitoring, Assistance,
and Media Programs Division, Office of
Compliance, Mail Code 2227A,
Environmental Protection Agency, 1200
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:39 May 25, 2018
Jkt 244001
Pennsylvania Ave. NW, Washington, DC
20460; telephone number: (202) 564–
2970; fax number: (202) 564–0050;
email address: yellin.patrick@epa.gov.
SUPPLEMENTARY INFORMATION:
Supporting documents, which explain
in detail the information that the EPA
will be collecting, are available in the
public docket for this ICR. The docket
can be viewed online at
www.regulations.gov or in person at the
EPA Docket Center, EPA West, Room
3334, 1301 Constitution Ave. NW,
Washington, DC. The telephone number
for the Docket Center is 202–566–1744.
For additional information about EPA’s
public docket, visit https://www.epa.gov/
dockets.
Abstract: The National Emission
Standards for Hazardous Air Pollutants
(NESHAP) for the regulations published
at 40 CFR part 63, subpart U were
proposed on June 12, 1995, promulgated
on September 5, 1996, and amended on
June 19, 2000, July 16, 2001, December
16, 2008, and April 21, 2011. These
regulations apply to existing and new
elastomer product process units (EPPU)
and associated equipment including
waste management units, maintenance
wastewater, heat exchange systems, and
equipment required by or utilized to
comply with this Subpart located at
facilities that are major sources of
hazardous air pollutants (HAPs) and are
classified in the Group I Polymers and
Resins source category. The Group I
Polymers and Resins source category
includes the following categories: Butyl
Rubber Production, Epichlorohydrin
Elastomers Production, Ethylene
Propylene Rubber Production, Hypalon
Production, Neoprene Production,
Nitrile Butadiene Rubber (NBR)
Production, Polybutadiene Rubber
Production, Polysulfide Rubber
Production, and Styrene Butadiene
Rubber and Latex Production. New
facilities include those that commenced
construction, or reconstruction after the
date of proposal. This ICR combines
burden from the 2011 amendment with
the burden associated with the existing
provisions of the rule. In general, all
NESHAP standards require initial
notifications, performance tests, and
periodic reports by the owners/
operators of the affected facilities. They
are also required to maintain records of
the occurrence and duration of any
startup, shutdown, or malfunction in
the operation of an affected facility, or
any period during which the monitoring
system is inoperative. These
notifications, reports, and records are
essential in determining compliance,
and are required of all affected facilities
subject to NESHAP. Any owner/
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
operator subject to the provisions of this
part shall maintain a file containing
these documents, and retain the file for
at least five years following the
generation date of such maintenance
reports and records. All reports are sent
to the delegated state or local authority.
In the event that there is no such
delegated authority, the reports are sent
directly to the United States
Environmental Protection Agency (EPA)
regional office.
Form Numbers: None.
Respondents/affected entities:
Facilities with elastomer product
process units and associated equipment.
Respondent’s obligation to respond:
Mandatory (40 CFR part 63, subpart U).
Estimated number of respondents: 19
(total).
Frequency of response: Initially,
occasionally, and semiannually.
Total estimated burden: 56,400 hours
(per year). Burden is defined at 5 CFR
1320.3(b).
Total estimated cost: $11,200,000 (per
year), includes $5,230,000 annualized
capital or operation & maintenance
costs.
Changes in the Estimates: There is an
adjustment increase in the total
estimated burden, labor costs, and
capital and O&M costs as currently
identified in the OMB Inventory of
Approved Burdens. This increase is not
due to any program changes. The
change in the burden and cost estimates
occurred because the previously
approved ICR only covered the burden
and costs associated with the 2011
amendment. This ICR combines the
burden from both the 2011 amendment
and the pre-2011 provisions of the rule.
Courtney Kerwin,
Director, Collection Strategies Division.
[FR Doc. 2018–11450 Filed 5–25–18; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OECA–2013–0349; FRL–9978–
60–OEI]
Information Collection Request
Submitted to OMB for Review and
Approval; Comment Request; NESHAP
for Pharmaceuticals Production
(Renewal)
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
The Environmental Protection Agency
has submitted an information collection
request (ICR)—NESHAP for
Pharmaceuticals Production (40 CFR
E:\FR\FM\29MYN1.SGM
29MYN1
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 103 / Tuesday, May 29, 2018 / Notices
part 63, subpart GGG) (Renewal), EPA
ICR Number 1781.08, OMB Control
Number 2060–0358—to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act. This is a
proposed extension of the ICR, which is
currently approved through May 31,
2018. Public comments were previously
requested via the Federal Register (82
FR 29552) on June 29, 2017 during a 60day comment period. This notice allows
for an additional 30 days for public
comments. A fuller description of the
ICR is given below, including its
estimated burden and cost to the public.
An agency may neither conduct nor
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.
DATES: Additional comments may be
submitted on or before June 28, 2018.
ADDRESSES: Submit your comments,
referencing Docket ID Number EPA–
HQ–OECA–2013–0349, to: (1) EPA
online using www.regulations.gov (our
preferred method), or by email to
docket.oeca@epa.gov, or by mail to: EPA
Docket Center, Environmental
Protection Agency, Mail Code 28221T,
1200 Pennsylvania Ave. NW,
Washington, DC 20460; and (2) OMB via
email to oira_submission@omb.eop.gov.
Address comments to OMB Desk Officer
for EPA.
EPA’s policy is that all comments
received will be included in the public
docket without change, including any
personal information provided, unless
the comment includes profanity, threats,
information claimed to be Confidential
Business Information (CBI), or other
information whose disclosure is
restricted by statute.
FOR FURTHER INFORMATION CONTACT:
Patrick Yellin, Monitoring, Assistance,
and Media Programs Division, Office of
Compliance, Mail Code 2227A,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC
20460; telephone number: (202) 564–
2970; fax number: (202) 564–0050;
email address: yellin.patrick@epa.gov.
SUPPLEMENTARY INFORMATION:
Supporting documents, which explain
in detail the information that the EPA
will be collecting, are available in the
public docket for this ICR. The docket
can be viewed online at
www.regulations.gov or in person at the
EPA Docket Center, WJC West, Room
3334, 1301 Constitution Ave. NW,
Washington, DC. The telephone number
for the Docket Center is 202–566–1744.
For additional information about EPA’s
public docket, visit: https://
www.epa.gov/dockets.
VerDate Sep<11>2014
16:39 May 25, 2018
Jkt 244001
Abstract: The National Emission
Standards for Hazardous Air Pollutants
(NESHAP) for Pharmaceuticals
Production (40 CFR part 63, subpart
GGG) were proposed on April 2, 1997;
promulgated on September 21, 1998;
and amended on both April 21, 2011
and February 27, 2014. The 2014
amendment promulgated technical
correction was made to allow for EPA
Method 320 as an alternative to EPA
Method 18 for demonstrating that a
‘vent’ is not a process vent. These
regulations apply to existing and new
pharmaceuticals manufacturing
operations that are major sources of
hazardous air pollutants (HAP). The
affected facilities encompass all
pharmaceuticals manufacturing
operations that include process vents,
storage tanks, equipment components,
and wastewater systems. New facilities
include those that commenced
construction or reconstruction after the
date of proposal. This information is
being collected to assure compliance
with 40 CFR part 63, subpart GGG. In
general, all NESHAP standards require
initial notifications, performance tests,
and periodic reports by the owners/
operators of the affected facilities. They
are also required to maintain records of
the occurrence and duration of any
startup, shutdown, or malfunction in
the operation of an affected facility, or
any period during which the monitoring
system is inoperative. These
notifications, reports, and records are
essential in determining compliance,
and are required of all affected facilities
subject to NESHAP. Any owner/
operator subject to the provisions of this
part shall maintain a file containing
these documents, and retain the file for
at least five years following the
generation date of such maintenance
reports and records. All reports are sent
to the delegated state or local authority.
In the event that there is no such
delegated authority, the reports are sent
directly to the U.S. Environmental
Protection Agency (EPA) regional office.
Form Numbers: None.
Respondents/affected entities:
Pharmaceutical manufacturing
operations.
Respondent’s obligation to respond:
Mandatory (40 CFR part 63, subpart
GGG).
Estimated number of respondents: 27
(total).
Frequency of response: Initially,
occasionally, quarterly and
semiannually.
Total estimated burden: 44,300 hours
(per year). Burden is defined at 5 CFR
1320.3(b).
Total estimated cost: $4,760,000 (per
year), which includes $112,000 in either
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
24473
annualized capital and/or operation &
maintenance costs.
Changes in the Estimates: There is a
reduction in the estimated number of
responses, by one. The previous ICR
included one response for affirmative
defense. However, that item has
subsequently been removed from this
ICR as those provisions are outdated.
There is an adjustment increase in the
respondent labor hours as currently
identified in the OMB Inventory of
Approved Burdens. This increase is not
due to any program changes. The
change in the burden and cost estimates
occurred due to a change in assumption.
In accordance with the Terms of
Clearance, this ICR assumes all existing
respondents will have to familiarize
with the regulatory requirements each
year. There is also a small adjustment
decrease in the total capital and O&M
costs as compared the previouslyapproved ICR. This decrease is not due
to any program changes, but occurred
because, in accordance with the terms of
clearance, this ICR rounds totals to three
significant figures.
Courtney Kerwin,
Director, Regulatory Support Division.
[FR Doc. 2018–11449 Filed 5–25–18; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL ELECTION COMMISSION
Sunshine Act Meetings
FEDERAL REGISTER CITATION NOTICE OF
PREVIOUS ANNOUNCEMENT: 83 FR 23682.
PREVIOUSLY ANNOUNCED TIME AND DATE OF
THE MEETING: Thursday, May 24, 2018
at 10:00 a.m.
The Following
Item Was Also Discussed: Adoption of
Forty Year Report.
CONTACT PERSON FOR MORE INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
CHANGES IN THE MEETING:
Dayna C. Brown,
Secretary and Clerk of the Commission.
[FR Doc. 2018–11552 Filed 5–24–18; 4:15 pm]
BILLING CODE 6715–01–P
FEDERAL ELECTION COMMISSION
[Notice 2018–10]
Filing Dates for the Pennsylvania
Special Election in the 7th
Congressional District
Federal Election Commission.
Notice of filing dates for special
election.
AGENCY:
ACTION:
E:\FR\FM\29MYN1.SGM
29MYN1
Agencies
[Federal Register Volume 83, Number 103 (Tuesday, May 29, 2018)]
[Notices]
[Pages 24472-24473]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-11449]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OECA-2013-0349; FRL-9978-60-OEI]
Information Collection Request Submitted to OMB for Review and
Approval; Comment Request; NESHAP for Pharmaceuticals Production
(Renewal)
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
The Environmental Protection Agency has submitted an information
collection request (ICR)--NESHAP for Pharmaceuticals Production (40 CFR
[[Page 24473]]
part 63, subpart GGG) (Renewal), EPA ICR Number 1781.08, OMB Control
Number 2060-0358--to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act.
This is a proposed extension of the ICR, which is currently approved
through May 31, 2018. Public comments were previously requested via the
Federal Register (82 FR 29552) on June 29, 2017 during a 60-day comment
period. This notice allows for an additional 30 days for public
comments. A fuller description of the ICR is given below, including its
estimated burden and cost to the public. An agency may neither conduct
nor sponsor, and a person is not required to respond to, a collection
of information unless it displays a currently valid OMB control number.
DATES: Additional comments may be submitted on or before June 28, 2018.
ADDRESSES: Submit your comments, referencing Docket ID Number EPA-HQ-
OECA-2013-0349, to: (1) EPA online using www.regulations.gov (our
preferred method), or by email to [email protected], or by mail to:
EPA Docket Center, Environmental Protection Agency, Mail Code 28221T,
1200 Pennsylvania Ave. NW, Washington, DC 20460; and (2) OMB via email
to [email protected]. Address comments to OMB Desk Officer
for EPA.
EPA's policy is that all comments received will be included in the
public docket without change, including any personal information
provided, unless the comment includes profanity, threats, information
claimed to be Confidential Business Information (CBI), or other
information whose disclosure is restricted by statute.
FOR FURTHER INFORMATION CONTACT: Patrick Yellin, Monitoring,
Assistance, and Media Programs Division, Office of Compliance, Mail
Code 2227A, Environmental Protection Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460; telephone number: (202) 564-2970; fax number:
(202) 564-0050; email address: [email protected].
SUPPLEMENTARY INFORMATION: Supporting documents, which explain in
detail the information that the EPA will be collecting, are available
in the public docket for this ICR. The docket can be viewed online at
www.regulations.gov or in person at the EPA Docket Center, WJC West,
Room 3334, 1301 Constitution Ave. NW, Washington, DC. The telephone
number for the Docket Center is 202-566-1744. For additional
information about EPA's public docket, visit: https://www.epa.gov/dockets.
Abstract: The National Emission Standards for Hazardous Air
Pollutants (NESHAP) for Pharmaceuticals Production (40 CFR part 63,
subpart GGG) were proposed on April 2, 1997; promulgated on September
21, 1998; and amended on both April 21, 2011 and February 27, 2014. The
2014 amendment promulgated technical correction was made to allow for
EPA Method 320 as an alternative to EPA Method 18 for demonstrating
that a `vent' is not a process vent. These regulations apply to
existing and new pharmaceuticals manufacturing operations that are
major sources of hazardous air pollutants (HAP). The affected
facilities encompass all pharmaceuticals manufacturing operations that
include process vents, storage tanks, equipment components, and
wastewater systems. New facilities include those that commenced
construction or reconstruction after the date of proposal. This
information is being collected to assure compliance with 40 CFR part
63, subpart GGG. In general, all NESHAP standards require initial
notifications, performance tests, and periodic reports by the owners/
operators of the affected facilities. They are also required to
maintain records of the occurrence and duration of any startup,
shutdown, or malfunction in the operation of an affected facility, or
any period during which the monitoring system is inoperative. These
notifications, reports, and records are essential in determining
compliance, and are required of all affected facilities subject to
NESHAP. Any owner/operator subject to the provisions of this part shall
maintain a file containing these documents, and retain the file for at
least five years following the generation date of such maintenance
reports and records. All reports are sent to the delegated state or
local authority. In the event that there is no such delegated
authority, the reports are sent directly to the U.S. Environmental
Protection Agency (EPA) regional office.
Form Numbers: None.
Respondents/affected entities: Pharmaceutical manufacturing
operations.
Respondent's obligation to respond: Mandatory (40 CFR part 63,
subpart GGG).
Estimated number of respondents: 27 (total).
Frequency of response: Initially, occasionally, quarterly and
semiannually.
Total estimated burden: 44,300 hours (per year). Burden is defined
at 5 CFR 1320.3(b).
Total estimated cost: $4,760,000 (per year), which includes
$112,000 in either annualized capital and/or operation & maintenance
costs.
Changes in the Estimates: There is a reduction in the estimated
number of responses, by one. The previous ICR included one response for
affirmative defense. However, that item has subsequently been removed
from this ICR as those provisions are outdated. There is an adjustment
increase in the respondent labor hours as currently identified in the
OMB Inventory of Approved Burdens. This increase is not due to any
program changes. The change in the burden and cost estimates occurred
due to a change in assumption. In accordance with the Terms of
Clearance, this ICR assumes all existing respondents will have to
familiarize with the regulatory requirements each year. There is also a
small adjustment decrease in the total capital and O&M costs as
compared the previously-approved ICR. This decrease is not due to any
program changes, but occurred because, in accordance with the terms of
clearance, this ICR rounds totals to three significant figures.
Courtney Kerwin,
Director, Regulatory Support Division.
[FR Doc. 2018-11449 Filed 5-25-18; 8:45 am]
BILLING CODE 6560-50-P